Abstract
Axl-RTK Inhibition Modulates Monocyte Immune Response to Enhance the Anti-Tumor Effects of CD19 Redirected Chimeric Antigen Receptor T Cells in Preclinical Models
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have